These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7298626)

  • 1. Studies on the mechanism of denaturation of cytochrome P-450 by cyclophosphamide and its metabolites.
    Gurtoo HL; Marinello AJ; Struck RF; Paul B; Dahms RP
    J Biol Chem; 1981 Nov; 256(22):11691-701. PubMed ID: 7298626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and binding of cyclophosphamide and its metabolite acrolein to rat hepatic microsomal cytochrome P-450.
    Marinello AJ; Bansal SK; Paul B; Koser PL; Love J; Struck RF; Gurtoo HL
    Cancer Res; 1984 Oct; 44(10):4615-21. PubMed ID: 6380709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Denaturation of cytochrome P-450 by cyclophosphamide metabolites.
    Marinello AJ; Gurtoo HL; Struck RF; Paul B
    Biochem Biophys Res Commun; 1978 Aug; 83(4):1347-53. PubMed ID: 697865
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of cyclophosphamide by purified cytochrome P-450 from microsomes of phenobarbital-treated rats.
    Struck RF; Kari P; Kalin J; Montgomery JA; Marinello AJ; Love J; Bansal SK; Gurtoo HL
    Biochem Biophys Res Commun; 1984 Apr; 120(2):390-6. PubMed ID: 6732764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of 3,4,3',4'-tetrachlorobiphenyl to protein-bound metabolites by rat liver microsomal cytochrome P-448-containing monooxygenase system.
    Shimada T; Sawabe Y
    Toxicol Appl Pharmacol; 1983 Sep; 70(3):486-93. PubMed ID: 6415870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK; Waxman DJ
    Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide.
    Gurtoo HL; Hipkens JH; Sharma SD
    Cancer Res; 1981 Sep; 41(9 Pt 1):3584-91. PubMed ID: 7260917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic activation of 2-methylfuran by rat microsomal systems.
    Ravindranath V; Boyd MR
    Toxicol Appl Pharmacol; 1985 May; 78(3):370-6. PubMed ID: 4049387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of protein binding on acrolein turnover in vitro by oxazaphosphorines and liver microsomes.
    Baumann F; Schmidt R; Teichert J; Preiss R
    J Clin Lab Anal; 2005; 19(3):103-9. PubMed ID: 15900571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of cyclophosphamide metabolites with membrane proteins: an in vitro study with rabbit liver microsomes and human red blood cells. Effect of thiols.
    Wildenauer DB; Oehlmann CE
    Biochem Pharmacol; 1982 Nov; 31(22):3535-41. PubMed ID: 7181935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent binding of 14C- and 35S-labeled thiocarbamides in rat hepatic microsomes.
    Decker CJ; Doerge DR
    Biochem Pharmacol; 1992 Feb; 43(4):881-8. PubMed ID: 1371686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative metabolism of cyclophosphamide: identification of the hepatic monooxygenase catalysts of drug activation.
    Clarke L; Waxman DJ
    Cancer Res; 1989 May; 49(9):2344-50. PubMed ID: 2706622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and study of a spin-labeled cyclophosphamide analogue, 3-(1-oxy-2,2,6,6-tetramethyl-4-piperidinyl)cyclophosphamide.
    Tsui FP; Robey FA; Engle TW; Ludeman SM; Zon G
    J Med Chem; 1982 Sep; 25(9):1106-10. PubMed ID: 7131492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
    Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
    Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for peroxidase-mediated metabolism of cyclophosphamide.
    Kanekal S; Kehrer JP
    Drug Metab Dispos; 1993; 21(1):37-42. PubMed ID: 8095224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased antitumor activity of cyclophosphamide (Endoxan) following pretreatment with inducer of drug-metabolizing enzymes (cytochrome P-450).
    Oira S; Maezawa S; Irinoda Y; Watanabe K; Kitada K
    Tohoku J Exp Med; 1974 Sep; 114(1):55-60. PubMed ID: 4432244
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of thiols on toxicity and carcinostatic activity of cyclophosphamide.
    Gurtoo HL; Marinello AJ; Berrigan MJ; Bansal SK; Paul B; Pavelic ZP; Struck RF
    Semin Oncol; 1983 Mar; 10(1 Suppl 1):35-45. PubMed ID: 6836326
    [No Abstract]   [Full Text] [Related]  

  • 18. 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) modulates rat liver microsomal cyclophosphamide and ifosphamide activation by suppressing cytochrome P450 2C11 messenger RNA levels.
    Chang TK; Chen H; Waxman DJ
    Drug Metab Dispos; 1994; 22(5):673-9. PubMed ID: 7835216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes.
    Sawahata T; Neal RA
    Mol Pharmacol; 1983 Mar; 23(2):453-60. PubMed ID: 6835203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclophosphamide and its metabolite acrolein. Some studies on their porphyrinogenic action in 17 day old chick embryo.
    Cochón AC; San Martín de Viale LC; Wainstok de Calmanovici R
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 May; 102(1):143-8. PubMed ID: 1358518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.